2026 Annual Meeting | C144 - Neuro-oncology: Navigating Current Trends

Date Tuesday 04/21/26

Time 01:00 PM - 03:00 PM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Julie J. Miller, MD, PhD

Topic(s) Neuro-oncology

Learning Objectives Participants will be able to describe key genomic tests that should be incorporated in brain tumor diagnosis and explain how to integrate these tests into current treatment paradigms. Participants will review recent advances in pharmacologic management of brain tumor-related epilepsy and common medical complications, and discuss evidence-based approaches to treating these conditions.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
01:00 PM - 01:30 PM CDT	Speaker	Seeing the Target: Molecular Diagnostics for Glioma and Implications For Targeted Therapies Julie J. Miller, MD, PhD
01:30 PM - 02:00 PM CDT	Speaker	Update on Trends in Glioblastoma Management Lauren Schaff, MD, FAAN
02:00 PM - 02:30 PM CDT	Speaker	Brain-tumor Related Epilepsy: Guidelines and Cancer Neuroscience Steven Tobochnik, MD
02:30 PM - 03:00 PM CDT	Discussion	Interactive Tumor Board Julie J. Miller, MD, PhD, Lauren Schaff, MD, FAAN, Steven Tobochnik, MD

Faculty Disclosures
Julie J. Miller, MD, PhD	Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for npj Precision Oncology. The institution of Dr. Miller has received research support from NINDS. The institution of Dr. Miller has received research support from American Cancer Society - IRG Pilot Grant. The institution of Dr. Miller has received research support from Karyopharm. The institution of Dr. Miller has received research support from NCI. The institution of Dr. Miller has received research support from American Brain Tumor Association.
Lauren Schaff, MD, FAAN	Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ONO. Dr. Schaff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BTG Pharmaceuticals. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. The institution of Dr. Schaff has received research support from BTG, plc. The institution of Dr. Schaff has received research support from Merck. The institution of Dr. Schaff has received research support from DebioPharm.
Steven Tobochnik, MD	An immediate family member of Dr. Tobochnik has received personal compensation for serving as an employee of Google. Dr. Tobochnik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Blackrock Neurotech. Dr. Tobochnik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Blackrock Neurotech. The institution of Dr. Tobochnik has received research support from US Department of Veterans Affairs.

��ɫ��

��ɫ��